A Multicenter, Open-Label Trial to Assess the Safety and Tolerability of a Single Intravenous Loading Dose of Lacosamide Followed by Oral Maintenance as Adjunctive Therapy In Patients With Partial-Onset Seizures

被引：0
|
作者：
Fountain, N. B.
Krauss, G.
Isojarvi, J.
Dilley, D.
Doty, P.
Rudd, G.
机构：
[1] Univ Virginia, Charlottesville, VA USA
[2] Johns Hopkins Univ, Baltimore, MD USA
[3] Schwarz Biosci, Raleigh, NC USA
来源：
ANNALS OF EMERGENCY MEDICINE | 2010年 / 56卷 / 03期
关键词：
D O I：
10.1016/j.annemergmed.2010.06.139
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：S32 / S32
页数：1
相关论文
共 50 条
  • [21] Long-Term Safety of Lacosamide as Adjunctive Therapy in Patients with Uncontrolled Partial-Onset Seizures: Results from a Phase III Open-Label Extension Trial
    Husain, Aatif
    Faught, Raymond Edward
    Chung, Steve
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    NEUROLOGY, 2011, 76 (09) : A291 - A291
  • [22] Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures - An open-label trial
    Ferreira, Jose A.
    Le Pichon, Jean-Baptiste
    Abdelmoity, Ahmed T.
    Dilley, Deanne
    Dedeken, Peter
    Daniels, Tony
    Byrnes, William
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2019, 71 : 166 - 173
  • [23] Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: A multicentre open-label trial
    Zadeh, Wendy Waldman
    Escartin, Antonio
    Byrnes, William
    Tennigkeit, Frank
    Borghs, Simon
    Li, Ting
    Dedeken, Peter
    De Backer, Marc
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2015, 31 : 72 - 79
  • [24] Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial
    Mario López-Gómez
    Teresa Corona
    Araceli Diaz-Ruiz
    Camilo Ríos
    Neurological Sciences, 2011, 32 : 1063 - 1067
  • [25] Safety and tolerability of dapsone for the treatment of patients with drug-resistant, partial-onset seizures: an open-label trial
    Lopez-Gomez, Mario
    Corona, Teresa
    Diaz-Ruiz, Araceli
    Rios, Camilo
    NEUROLOGICAL SCIENCES, 2011, 32 (06) : 1063 - 1067
  • [26] Safety and efficacy of adjunctive lacosamide among patients with partial-onset seizures in a long-term open-label extension trial of up to 8 years
    Rosenfeld, William
    Fountain, Nathan B.
    Kaubrys, Gintaras
    Ben-Menachemd, Elinor
    McShea, Cindy
    Isojarvi, Jouko
    Doty, Pamela
    EPILEPSY & BEHAVIOR, 2014, 41 : 164 - 170
  • [27] LONG-TERM SAFETY AND TOLERABILITY OF LACOSAMIDE FOR PARTIAL-ONSET SEIZURES: AN INTERIM EVALUATION OF PATIENTS EXPOSED TO LACOSAMIDE IN DOUBLE-BLIND AND OPEN-LABEL TRIALS
    Rosenfeld, William
    Rosenow, F.
    Isojarvi, J.
    Hebert, D.
    Doty, P.
    EPILEPSIA, 2009, 50 : 262 - 262
  • [28] Long-Term Safety and Tolerability of Lacosamide for Partial-Onset Seizures: An Interim Evaluation of Patients Exposed to Lacosamide in Double-Blind and Open-Label Trials
    Rosenfeld, William
    Rosenow, Felix
    Isojarvi, Jouko
    Hebert, David
    Doty, Pamela
    NEUROLOGY, 2010, 74 (09) : A452 - A453
  • [29] Long-term exposure and safety of lacosamide monotherapy for the treatment of partial-onset (focal) seizures: Results from a multicenter, open-label trial
    Vossler, David G.
    Wechsler, Robert T.
    Williams, Paulette
    Byrnes, William
    Therriault, Sheila
    EPILEPSIA, 2016, 57 (10) : 1625 - 1633
  • [30] Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: Results from a phase III open-label extension trial
    Husain, Aatif
    Chung, Steve
    Faught, Edward
    Isojarvi, Jouko
    McShea, Cindy
    Doty, Pamela
    EPILEPSIA, 2012, 53 (03) : 521 - 528
12345